1 / 28

Benjamin Misemer, Amy Skubitz, Carlos Manivel,

Identification of Heterogeneity in Aggressive Fibromatosis: Validation by immunohistochemistry of markers identified by differential gene expression analyses. Benjamin Misemer, Amy Skubitz, Carlos Manivel,

ikia
Download Presentation

Benjamin Misemer, Amy Skubitz, Carlos Manivel,

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Identification of Heterogeneity in Aggressive Fibromatosis: Validation by immunohistochemistry of markers identified by differential gene expression analyses Benjamin Misemer, Amy Skubitz, Carlos Manivel, Stephen Schmechel, Edward Cheng, Jonathan Henriksen, Joseph Koopmeiners, and Keith Skubitz Masonic Cancer Center University of Minnesota Minneapolis

  2. Aggressive Fibromatosis (AF) • Characterized by a monoclonal proliferation of myofibroblasts • AF has a variable clinical course • Optimal treatment is unclear • WNT pathway, or beta-catenin pathway, has been implicated in pathogenesis

  3. AF – earlier studies Four genes (ADAM12, FAP-alpha, WISP-1, and Sox-11) were uniquely over-expressed in AF compared with 448 samples comprising 16 different normal tissues Skubitz, et al J Lab Clin Med 144:193-200, 2004.

  4. FAP-alpha • Integral membrane serine protease expressed in reactive stromal fibroblasts • FAP inhibition inhibits tumor growth in some mouse models

  5. WISP-1 (WNT-inducible signaling protein-1) • Growth factor that regulates diverse cellular functions • Enhances ECM deposition in fibroblasts • Up-regulated in Idiopathic Pulmonary Fibrosis • Up-regulated in a mouse model of bleomycin-induced lung fibrosis, where anti-WISP-1 attenuates fibrosis

  6. SOX-11 • Transcripton factor • Accelerates in vivo nerve regeneration

  7. ADAM-12 • A disintegrin and metalloprotease implicated in cell-cell and cell-matrix interactions

  8. ADAM-12 • Dulauroy et al recently identified ADAM12+ perivascular cells as a major source of profibrotic cells during acute tissue injury. These were a subset of PDGFR-alpha+ cells.

  9. AF – earlier studies Gene expression patterns suggested two distinct subgroups of AF; this may reflect disease biology Skubitz, et al J Lab Clin Med 144:193-200, 2004.

  10. Methods • To confirm protein expression in AF, immunohistochemistry (IHC) was performed on 29 AF cases

  11. Results • IHC revealed protein expression of each of the four probes. • ADAM12 staining in AF has been reported (Hajibashi et al, and Colombo et al.)

  12. FAP-alpha

  13. Methods • Automated imaging analysis was performed to quantify: • IHC staining • Nuclear size • Nuclear chromatin density

  14. ROI = Region of interest

  15. Methods • A nuclear chromatin density ratio (CDR) was defined to serve as a surrogate for nuclear activity = Nuclear area of light hematoxylin staining Nuclear area of dark staining

  16. Results • Nuclear size and chromatin density ratio (CDR) were strongly correlated (p<0.001). • Thus, CDR is a reasonable surrogate for nuclear size.

  17. Methods • A morphologic tumor activity score (MTA) was determined on 322 regions of interest (ROI) and correlated with nuclear size and CDR

  18. MTA Score

  19. Results • Both average nuclear size and CDR correlated with MTA score (p<0.001).

  20. Methods • The relationship between CDR and IHC staining intensity was assessed for each of the 4 proteins on ~26,000 ROIs from the 29 AF samples

  21. Results • Image analysis revealed moderate correlations between intensity of staining and CDR • ADAM12 r = 0.44, p<0.001 • FAP-alpha r = 0.39, p<0.001 • WISP-1 r = 0.27, p<0.001 • No significant correlation for SOX-11

  22. Conclusions • Confirmed protein expression of ADAM12, FAP, WISP-1, and SOX-11 in AF, found in our earlier gene expression studies • Prominent regional variation of morphologic tumor activity is present within and among AF cases

  23. Conclusions • These four proteins were more highly expressed in areas where cellular morphology suggested more active tumor cells. • These proteins may be involved in AF pathogenesis

  24. University of Minnesota • Sarah Bowell • Denis Clohisy • Stefan Pambuccian • Roby Thompson

More Related